Cardinal Health vs. UnitedHealth: Did the Underdog Win?
Roughly a year ago, 24/7 Wall St. argued that Cardinal Health (CAH) was a better healthcare stock than UnitedHealth (UNH). After 12 months, we examine the outcome and the outlook.
Key Numbers
About a year ago, 24/7 Wall St. published an analysis titled "Forget UnitedHealth. Cardinal Health Is the Best Healthcare Stock to Buy Right Now," arguing that Cardinal Health (NYSE: CAH) was the safer bet while UnitedHealth Group (NYSE: UNH) faced a DOJ probe, leadership changes, and a 50% drawdown.
Did the Prediction Come True?
After 12 months, we revisit the performance of both stocks.
Stock Performance
- UnitedHealth (UNH): Partially recovered from lows but still under regulatory and legal pressure.
- Cardinal Health (CAH): Maintained relative stability, but did it clearly outperform?
Rationale Behind the Original Analysis
The earlier analysis was based on:
- Federal investigations into UnitedHealth.
- Leadership changes at UNH.
- Cardinal Health's lower regulatory risk profile.
Current Context
Since then, UnitedHealth has continued restructuring, while Cardinal Health benefited from stable drug distribution operations. However, the question remains: was the analysis accurate?
What to Conclude
Without precise return figures, it's hard to declare a clear winner. Investors should monitor upcoming earnings reports from both companies for a definitive comparison.
Found this useful? Share it